Abstract: The present invention relates to novel compounds and a method for the prophylaxis and treatment of Inflammatory Bowel Disease (IBD) via the administration of an effective amount in a suitable pharmaceutical dosage form of an azobenzene compound of formula I or a pharmacologically acceptable salt, which is reductively cleaved to 5-aminosalicylic acid (5-ASA) by bacteria in the large intestine.
Abstract: Complexes of radiolabelled metals with N-(tri-substituted alkyl)-iminodiacetic acids or salts thereof having utility as radiopharmaceutical agents for monitoring the activity of an organ, their preparation and a method employing such complexes for externally monitoring the activity of an organ are disclosed.
Type:
Grant
Filed:
December 13, 1979
Date of Patent:
December 29, 1981
Assignee:
G. D. Searle & Co.
Inventors:
Patricia Frank, Stephen Kraychy, Ernest F. Le Von
Abstract: Complexes of technetium-99m with fructose 6-phosphate or fructose 1,6-diphosphate or salts thereof having utility as radiopharmaceutical agents for monitoring the activity of an organ, their preparation and a method employing such complexes for externally monitoring the activity of an organ are disclosed.
Type:
Grant
Filed:
December 14, 1979
Date of Patent:
November 17, 1981
Assignee:
G. D. Searle & Co.
Inventors:
Patricia Frank, Stephen Kraychy, Ernest F. Le Von
Abstract: Compounds of the formula ##STR1## wherein R is phenyl or substituted phenyl, R.sub.2 is hydrogen or C.sub.1 -C.sub.4 alkyl and pharmaceutically acceptable salts thereof disclosed. They are useful as antihypertensive agents, substantially devoid of diuretic activity.
Abstract: A process for selectively esterifying .alpha.-L-aspartyl-L-phenylalanine to the corresponding alkyl esters using a proteolytic enzyme with specific esterase activity is described. The process is carried out in an aqueous-alcohol medium in which the alcohol concentration is sufficient to reverse the esterase activity. The .alpha.-L-aspartyl-L-phenylalanine alkyl esters so produced are useful as artificial sweeteners.
Abstract: An improved process for the preparation of steroidal .DELTA..sup.4,6 dienones by the electrochemical dehydrogenation of the corresponding .DELTA..sup.3,5 enol ethers under basic conditions, using less than stochiometric amounds of a high potential catalyst, such as 2,3-dichloro-5,6-dicyano-benzoquinone, in a partially aqueous electrolyte solution.